Randomized placebo-controlled multicenter exploratory Phase IIA study to assess the safety and efficacy of PEG-liposomal prednisolone sodium phosphate (Nanocort) in subjects with active ulcerative colitis.

Registry ID

EUCTR2010-020448-37

Source registry

EUCTR

Status

Prematurely Ended

Phase

PHASE2

Sponsor

Enceladus Pharmaceuticals

Start date

2010-10-20

Last update

2026-08-16

Conditions

• Active Ulcerative Colitis

Summary

To evaluate the safety of PEG-liposomal prednisolone sodium phosphate (Nanocort)

Locations

• , , Netherlands
• , , Belgium

Related clinical trials

• An Early-Stage Study in Multiple Clinics of How Afimkibart May Affect the Body's Processing of Medicines That Rely on Cytochrome P450 Enzymes in Participants With Ulcerative Colitis
• Superdonor FMT in Patients With Ulcerative Colitis

View on source registry